SEARCH

SEARCH BY CITATION

References

  • 1
    Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France and Australia: transmission and prospects of control. Epidemiol Infect 2008; 136(6):852864.
  • 2
    Hardelid P, Fleming DM, Andrews N et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine 2012; 30(7):13711378.
  • 3
    Pebody R, Hardelid P, Fleming DM et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill 2011; 16(6):813.
  • 4
    HPA group. Influenza vaccine composition. Health Protection Agency 2012 February 28; Available at http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733812968#north1011 (Accessed 13 June 2012).
  • 5
    HPA group. Frequently asked questions on influenza. Health Protection Agency 2013 February 8; Available at http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733852084 (Accessed 4 April 2013).
  • 6
    Begum F, Pebody R. Seasonal influenza vaccine uptake amongst GP patient groups in England. Department of Health 2011 July 19; Available at http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_129856.pdf (Accessed 13 June 2012).
  • 7
    Kavanagh K, Robertson C, McMenamin J. Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach. PLoS ONE 2011; 6(12):e28743.
  • 8
    Puig-Barbera J. 2010-2011 influenza seasonal vaccine, preliminary mid-season effectiveness estimates: reason for concern, confounding or are we following the right track? Euro Surveill 2011; 16(11):pii: 19821.
  • 9
    Stata [computer program]. Version 12.0. College Station, TX, 2011.
  • 10
    Pebody RG, Andrews N, Fleming DM et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2012; 111. [Epub ahead of print]
  • 11
    Castilla J, Martínez-Artola V, Salcedo E et al. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012; 30(2):195200.
  • 12
    Kissling E, Valenciano M, Cohen JM et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS ONE 2011; 6(11):e27622.
  • 13
    HPA group. Surveillance of Influenza and other respiratory viruses in the UK. Health Protection Agency 2011; Available at http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1296687414154 (Accessed 12 December 2012).
  • 14
    Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12(1):3644.
  • 15
    Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004; 190(1):110.